48 related articles for article (PubMed ID: 26124323)
21. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
24. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.
Lee PP; Yee C; Savage PA; Fong L; Brockstedt D; Weber JS; Johnson D; Swetter S; Thompson J; Greenberg PD; Roederer M; Davis MM
Nat Med; 1999 Jun; 5(6):677-85. PubMed ID: 10371507
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
Song JH; Song DK; Herlyn M; Petruk KC; Hao C
Clin Cancer Res; 2003 Sep; 9(11):4255-66. PubMed ID: 14519653
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance.
Su Y; Bintz M; Yang Y; Robert L; Ng AHC; Liu V; Ribas A; Heath JR; Wei W
PLoS Comput Biol; 2019 Jun; 15(6):e1007034. PubMed ID: 31166947
[TBL] [Abstract][Full Text] [Related]
27.
Hsu DM; Shohet JM; Kim ES
Bio Protoc; 2014 Apr; 4(8):. PubMed ID: 27540563
[TBL] [Abstract][Full Text] [Related]
28. Rare, yet relevant tumor cells - A new twist to melanoma cell plasticity.
Zingg D; Sommer L
Pigment Cell Melanoma Res; 2018 Jan; 31(1):7-9. PubMed ID: 28898550
[No Abstract] [Full Text] [Related]
29. Gene Expression of
Bark SA; Dalmolin M; Malafaia O; Roesler R; Fernandes MAC; Isolan GR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474265
[TBL] [Abstract][Full Text] [Related]
30. Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.
Kučera J; Strnadová K; Dvořánková B; Lacina L; Krajsová I; Štork J; Kovářová H; Skalníková HK; Vodička P; Motlík J; Dundr P; Smetana K; Kodet O
Oncol Rep; 2019 Nov; 42(5):1793-1804. PubMed ID: 31545456
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko IV; Kalinovsky DV; Doronin II; Deyev SM; Kholodenko RV
J Immunol Res; 2018; 2018():7394268. PubMed ID: 30116755
[TBL] [Abstract][Full Text] [Related]
32. Characterization of G-CSF receptor expression in medulloblastoma.
Paul MR; Huo Y; Liu A; Lesperance J; Garancher A; Wechsler-Reya RJ; Zage PE
Neurooncol Adv; 2020; 2(1):vdaa062. PubMed ID: 32642714
[TBL] [Abstract][Full Text] [Related]
33. GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML.
Hanumanthu VS; Pirruccello SJ
Am J Clin Pathol; 2013 Aug; 140(2):155-64. PubMed ID: 23897249
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab.
Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F
Anticancer Drugs; 2008 Aug; 19(7):689-96. PubMed ID: 18594210
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.
Ju DW; Cao X; Acres B
Cancer Gene Ther; 1997; 4(2):139-44. PubMed ID: 9080123
[TBL] [Abstract][Full Text] [Related]
36. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
Zage PE; Whittle SB; Shohet JM
J Cell Biochem; 2017 Feb; 118(2):221-231. PubMed ID: 27428599
[TBL] [Abstract][Full Text] [Related]
37. CD114 Expression Mediates Melanoma Tumor Cell Growth and Treatment Resistance.
Zhang L; Agarwal S; Shohet JM; Zage PE
Anticancer Res; 2015 Jul; 35(7):3787-92. PubMed ID: 26124323
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
